NCT00006485View on ClinicalTrials.gov

Flavopiridol and Irinotecan in Treating Patients With Advanced Solid Tumors

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

September 30, 2000

Primary Completion Date

December 31, 2003

Conditions
Unspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG

alvocidib

DRUG

irinotecan hydrochloride

Trial Locations (1)

10021

Memorial Sloan-Kettering Cancer Center, New York

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT00006485 - Flavopiridol and Irinotecan in Treating Patients With Advanced Solid Tumors | Biotech Hunter | Biotech Hunter